Acquisition of Multidrug-Resistant Pseudomonas aeruginosa in Patients in Intensive Care Units: Role of Antibiotics with Antipseudomonal Activity

Paramythiotou, Elisabeth; Lucet, Jean-Christophe; Timsit, Jean-François; Vanjak, Dominique; Paugam-Burtz, Catherine; Trouillet, Jean-Louis; Belloc, Stéphanie; Kassis, Najiby; Karabinis, Andreas; Andremont, Antoine
March 2004
Clinical Infectious Diseases;3/1/2004, Vol. 38 Issue 5, p670
Academic Journal
A matched case-control study was performed to identify risk factors for acquiring multidrug-resistant Pseudomonas aeruginosa (MDRPA) in intensive care unit (ICU) patients during a 2-year period. MDRPA was defined as P. aeruginosa with combined decreased susceptibility to piperacillin, ceftazidime, imipenem, and ciprofloxacin. Thirty-seven patients who were colonized or infected with MDRPA were identified, 34 of whom were matched with 34 control patients who had cultures that showed no growth of P. aeruginosa. Matching criteria were severity of illness and length of ICU stay, with each control patient staying in the ICU for at least as long as the time period between the corresponding case patient's admission to the ICU and the acquisition of MDRPA. Baseline demographic and clinical characteristics and the use of invasive procedures were similar for case patients and control patients. Multivariate analysis identified duration of ciprofloxacin treatment as an independent risk factor for MDRPA acquisition, whereas the duration of treatment with imipenem was of borderline significance. These data support a major role for the use of antibiotics with high antipseudomonal activity, particularly ciprofloxacin, in the emergence of MDRPA.


Related Articles

  • Integron-associated resistance genes among multidrug-resistant Pseudomonas aeruginosa isolated from clinical specimens. Budak, Fatma; Kasap, Murat; Kolayli, Fetiye; Karadenızlı, Aynur; Vahaboğlu, Mustafa Haluk // Turkish Journal of Medical Sciences;Feb2012, Vol. 42 Issue 1, p149 

    Aim: To characterize common beta-lactamase genes and the role of integrons in beta-lactam antibiotic resistance among multidrug-resistant (MDR) P. aeruginosa strains isolated from intensive care units in Turkey. Materials and methods: After the examination of 67 P. aeruginosa isolates, 14 were...

  • Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa. Giamarellos-Bourboulis, Evangelos J.; Antonopoulo, Anastasia; Raftogiannis, Maria; Koutoukas, Pantelis; Tsaganos, Thomas; Tziortzioti, Vassiliki; Panagou, Charalambos; Adamis, Theodoros; Giamarellou, Helen // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p1 

    Background: To apply clarithromycin as an immunomodulatory treatment in experimental urosepsis by multidrug-resistant Pseudomonas aeruginosa. Methods: Acute pyelonephritis was induced in 40 rabbits after inoculation of the test isolate in the renal pelvis. Therapy was administered upon signs of...

  • Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy. Jumbe, Nelson; Louie, Arnold; Leary, Robert; Weigou Liu; Deziel, Mark R.; Tam, Vincent H.; Bachhawat, Reetu; Freeman, Christopher; Kahn, James B; Bush, Karen; Dudley, Michael N.; Miller, Michael H.; Drusano, George L. // Journal of Clinical Investigation;Jul2003, Vol. 112 Issue 2, p275 

    Presents a study which developed a mathematical model that described relationships between antimicrobial drug exposures and changes in drug-susceptible and -resistant bacterial subpopulations at an infection site using data derived from mice infected with bacterium Pseudomonas aeruginosa and...

  • Bacterial-Population Responses to Drug-Selective Pressure: Examination of Garenoxacin's Effect on Pseudomonas aeruginosa. Tam, Vincent H.; Louie, Arnold; Deziel, Mark R.; Weiguo Liu; Leary, Robert; Drusano, George L. // Journal of Infectious Diseases;8/1/2005, Vol. 192 Issue 3, p420 

    The emergence of resistance to antibiotics is a serious problem often related to suboptimal drug dosing; such suboptimal dosing results in the preferential killing of drug-susceptible microbial subpopulations, allowing amplification of drug-resistant microbial subpopulations. We determined the...

  • A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.  // BMC Infectious Diseases;2011, Vol. 11 Issue 1, p272 

    The article focuses on a study which aims at analyzing the endemic outbreak of multiresistant Pseudomonas aeruginosa (MRPA) infection at the Hospital Universitari de Bellvitge in Spain. It explains the methodology of the study which revealed that 22 percent of intensive care unit (ICU) patients...

  • Efflux Mechanism, an Attractive Target to Combat Multidrug Resistant Plasmodium falciparum and Pseudomonas aeruginosa. Alibert-Franco, Sandrine; Pradines, Bruno; Mahamoud, Abdallah; Davin-Regli, Anne; Pag�s, Jean-Marie // Current Medicinal Chemistry;Jan2009, Vol. 16 Issue 2, p301 

    Chemoresistance is a general health problem concerning infectious diseases and cancer treatments. In this context, the worldwide dissemination of � pandrug � and � multidrug� resistant pathogens has severely compromised the efficacy of our antimicrobial weapons and...

  • LETTERS. Tacconelli, Evelina; Tumbarello, Mario; Bertagnolio, Silvia; Citton, Rita; Spanu, Teresa; Fadda, Giovanni; Cauda, Roberto // Emerging Infectious Diseases;Feb2002, Vol. 8 Issue 2, p220 

    Discusses a study which investigated the percentage and clinical findings of patients with Pseudomonas aeruginosa bloodstream infection having multidrug-resistant (MDR) strain in Rome, Italy from 1990 to 1999. Patients and materials; Incidence of both nosocomial and community acquired P....

  • Antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from a Malaysian Hospital. PATHMANATHAN, Siva Gowri; SAMAT, Nor Azura; MOHAMED, Ramelah // Malaysian Journal of Medical Sciences;Apr2009, Vol. 16 Issue 2, p28 

    Ongoing surveillance of Pseudomonas aeruginosa resistance against antimicrobial agents is fundamental to monitor trends in susceptibility patterns and to appropriately guide clinicians in choosing empirical or directed therapy. The in vitro activity level of eight antimicrobial drugs was...

  • Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. Landman, David; Kelly, Paul; Bäcker, Martin; Babu, Elizabeth; Shah, Neha; Bratu, Simona; Quale, John // Journal of Antimicrobial Chemotherapy (JAC);Feb2011, Vol. 66 Issue 2, p332 

    Objectives Multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa have become a global problem, often leaving the polymyxins as therapeutic agents of last resort. ACHN-490, a next-generation aminoglycoside with activity against a broad range of Gram-positive and Gram-negative...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics